Refresher Course: Hybrid, Molecular and Translational Imaging
RC 1206 - Hands-on theranostics: focus on prostate cancer diagnostics and treatment
Lectures
1
Chairperson's introduction
04:00Amy Eccles, London / UK
2
Staging and therapy monitoring of prostate cancer
20:00Johannes Rübenthaler, Munich / DE
3
Prerequisites for PSMA therapy: what we need to know and how we find it
12:00James Nagarajah, Nijmegen / NL
4
Basics of radioligand therapy: PSMA and beyond
12:00Alexander Walter Sauter, Baden / CH
5
Panel discussion: Chances and challenges of interdisciplinary image-guided therapy
12:00Panel discussion: Chances and challenges of interdisciplinary image-guided therapy
4 min
Chairperson's introduction
Amy Eccles, London / United Kingdom
20 min
Staging and therapy monitoring of prostate cancer
Johannes Rübenthaler, Munich / Germany
- To learn about the crucial role of PSMA PET in the primary staging of prostate cancer.
- To appreciate the limitations of PSMA PET in, e.g. advanced disease.
- To understand the principles of hybrid imaging for cancer staging.
12 min
Prerequisites for PSMA therapy: what we need to know and how we find it
James Nagarajah, Nijmegen / Netherlands
- To learn about principles of patient selection for PSMA therapy.
- To appreciate the role of PSMA therapy in the concept and guidelines for prostate cancer treatment.
- To understand the role of imaging in patient selection for PSMA therapy.
12 min
Basics of radioligand therapy: PSMA and beyond
Alexander Walter Sauter, Baden / Switzerland
- To learn about the chemical and physical basics of radioligand therapy.
- To appreciate the specific challenges and chances of PSMA-targeted therapy.
- To understand how targeted therapy can benefit cancer patients
12 min
Panel discussion: Chances and challenges of interdisciplinary image-guided therapy